Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,348.90 +210.79 1.39%
Hang Seng 23,474.10 +391.43 1.70%
S&P/ASX 200 5,228.00 +47.23 0.91%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Forest Laboratories Inc

+ Add to Watchlist

FRX:US

38.5300 USD 0.1700 0.44%

As of 20:04:04 ET on 05/17/2013.

Company Profile for Forest Laboratories Inc (FRX)

Forest Laboratories, Inc. develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners.

Contact Information

Forest Laboratories Inc

909 Third Avenue
New York, NY 10022
United States
Phone: 1-212-421-7850
Fax: 1-212-750-9152

Key Executives for Forest Laboratories Inc (FRX)

Howard SolomonChairman/President/CEOElaine HochbergExec VP/Chief Commercial Ofcr
Herschel S WeinsteinSenior VP/Secretary/General CounselDavid F SolomonSenior VP:Corporate Development
Marco TagliettiSenior VP:Research & DevelopmentFrank J MurdoloVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil